Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.
Florimond C. et al, (2024), The Lancet. Infectious diseases, 24, 161 - 171
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Mehdipour P. et al, (2023), Malaria Journal, 22
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
Thriemer K. et al, (2023), BMC Medical Research Methodology, 23
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Dahal P. et al, (2022), Malaria Journal, 21
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
Mansoor R. et al, (2022), BMC Medicine, 20
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
MalariaGEN None. et al, (2022), Wellcome open research, 7
Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.
Adhikari B. et al, (2021), Malaria journal, 20
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
Awab GR. et al, (2021), eLife, 10
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
Rakmark K. et al, (2020), Malaria journal, 19
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Newton PN. et al, (2020), The Lancet Global Health, 8, e754 - e755
Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data
Devine A. et al, (2019), Bulletin of the World Health Organization, 97, 828 - 836
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Taylor WRJ. et al, (2019), The Lancet, 394, 929 - 938
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
Commons RJ. et al, (2018), The Lancet Infectious Diseases, 18, 1025 - 1034